du125530
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2004 (NCT01119430)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 1a (5-HT1a) receptorANTAGONIST
HTR1A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- du125530
- du125530
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01119430 | Phase 2 | May 1, 2004 | Hospital de Sant Pau i Santa Tecla de Tarragona, University of Barcelona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital de Sant Pau i Santa Tecla de Tarragona | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Barcelona | Academic/Hospital | 1 | 1 | 1 | 2004 |
2 organizations
Page 1 / 1